|
1）Caballo C, Palomo M, Cases A, et al. NFkappaB in the development of endothelial activation and damage in uremia: an in vitro approach. PLoS One. 2012; 7: e43374
|
|
|
|
2）Zhu L, Shi S, Liu L, et al. Increased plasma sVCAM-1 is associated with severity in IgA nephropathy. BMC Nephrol. 2013; 14: 21
|
|
|
|
|
3）Kodera R, Shikata K, Kataoka HU, et al. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia. 2011; 54: 965-78
|
|
|
|
|
|
4）Matsushita Y, Ogawa D, Wada J, et al. Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice. Diabetes. 2011; 60: 960-8
|
|
|
|
|
|
5）Kidokoro K, Satoh M, Nagasu H, et al. Tacrolimus induces glomerular injury via endothelial dysfunction caused by reactive oxygen species and inflammatory change. Kidney Blood Press Res. 2012; 35: 549-57
|
|
|
|
|
|
6）Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000; 87: 840-4
|
|
|
|
|
|
7）Xu J, Wu Y, Song P, et al. Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation. 2007; 116: 944-53
|
|
|
|
|
|
8）Satoh M, Fujimoto S, Haruna Y, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol. 2005; 288: F1144-52
|
|
|
|
|
|
9）Cheng H, Wang H, Fan X, et al. Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice. Kidney Int. 2012; 82: 1176-83
|
|
|
|
|
|
10）Kidokoro K, Satoh M, Channon KM, et al. Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy. J Am Soc Nephrol. 2013; 24: 1139-50
|
|
|
|
|
|
11）Li H, Forstermann U. Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease. Curr Opin Pharmacol. 2013; 13: 161-7
|
|
|
|
|
|
12）Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev. 2008; 88: 451-87
|
|
|
|
|
|
13）Deen WM. What determines glomerular capillary permeability? J Clin Invest. 2004; 114: 1412-4
|
|
|
|
|
|
14）van den Berg BM, Vink H, Spaan JA. The endothelial glycocalyx protects against myocardial edema. Circ Res. 2003; 92: 592-4
|
|
|
|
|
|
15）Kuwabara A, Satoh M, Tomita N, et al. Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats. Diabetologia. 2010; 53: 2056-65
|
|
|
|
|
|
16）Friden V, Oveland E, Tenstad O, et al. The glomerular endothelial cell coat is essential for glomerular filtration. Kidney Int. 2011; 79: 1322-30
|
|
|
|
|
|
17）Salmon AH, Satchell SC. Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol. 2012; 226: 562-74
|
|
|
|
|
|
18）Nieuwdorp M, Mooij HL, Kroon J, et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes. 2006; 55: 1127-32
|
|
|
|
|
|
19）Singh A, Friden V, Dasgupta I, et al. High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am J Physiol Renal Physiol. 2011; 300: F40-8
|
|
|
|
|
|
20）Singh A, Ramnath RD, Foster RR, et al. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS One. 2013; 8: e55852
|
|
|
|
|
|
21）van den Berg BM, Spaan JA, Rolf TM, et al. Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation. Am J Physiol Heart Circ Physiol. 2006; 290: H915-20
|
|
|
|
|
|
22）Constantinescu AA, Vink H, Spaan JA. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol. 2003; 23: 1541-7
|
|
|
|
|
|
23）Pahakis MY, Kosky JR, Dull RO, et al. The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress. Biochem Biophys Res Commun. 2007; 355: 228-33
|
|
|
|
|
|
24）Satchell SC, Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol. 2009; 296: F947-56
|
|
|
|
|
|
25）Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int. 2008; 74: 22-36
|
|
|
|
|
|
26）Weil EJ, Lemley KV, Mason CC, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int. 2012; 82: 1010-7
|
|
|
|
|
|
27）Toyoda M, Najafian B, Kim Y, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes. 2007; 56: 2155-60
|
|
|
|
|
|
28）Nakagawa T, Sato W, Glushakova O, et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol. 2007; 18: 539-50
|
|
|
|
|
|
29）Nakayama T, Sato W, Kosugi T, et al. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am J Physiol Renal Physiol. 2009; 296: F317-27
|
|
|
|
|
|
30）Sun YB, Qu X, Zhang X, et al. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy. PLoS One. 2013; 8: e55027
|
|
|
|
|
|
31）Yuen DA, Stead BE, Zhang Y, et al. eNOS deficiency predisposes podocytes to injury in diabetes. J Am Soc Nephrol. 2012; 23: 1810-23
|
|
|
|
|
|
32）Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008; 358: 1129-36
|
|
|
|
|
|
33）Sivaskandarajah GA, Jeansson M, Maezawa Y, et al. Vegfa protects the glomerular microvasculature in diabetes. Diabetes. 2012; 61: 2958-66
|
|
|
|
|